4‐Methyl‐5‐(4‐methylphenyl)‐4,5‐dihydrooxazol‐2‐amine (4,4′‐DMAR, 4,4′‐dimethylaminorex): availability, prevalence of use, desired effects and acute toxicity

ConclusionsCurrently, there appears to limited availability of 4,4′‐DMAR; therefore, use is likely to be low. Its desired and unwanted effects appear similar to other sympathomimetic recreational drugs such as methylenedioxy‐methamphetamine or mephedrone. Copyright © 2015 John Wiley & Sons, Ltd.
Source: Human Psychopharmacology: Clinical and Experimental - Category: Psychiatry Authors: Tags: Research Article Source Type: research